ANET vs. KRYS
ANET (Arista Networks, Inc.) and KRYS (Krystal Biotech, Inc.) are both stocks. ANET operates in Computer Hardware (Technology), while KRYS operates in Biotechnology (Healthcare). Over the past 5 years, ANET returned 51.24%/yr vs 39.65%/yr for KRYS. At a 0.24 correlation, their price movements are largely independent.
Performance
ANET vs. KRYS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANET achieves a 42.68% return, which is significantly lower than KRYS's 48.38% return.
ANET
- 1D
- 1.23%
- 1M
- 19.54%
- 6M
- 52.14%
- YTD
- 42.68%
- 1Y
- 72.20%
- 3Y*
- 67.14%
- 5Y*
- 51.24%
- 10Y*
- 45.55%
KRYS
- 1D
- -1.46%
- 1M
- 13.77%
- 6M
- 39.94%
- YTD
- 48.38%
- 1Y
- 146.89%
- 3Y*
- 43.91%
- 5Y*
- 39.65%
- 10Y*
- —
ANET vs. KRYS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ANET Arista Networks, Inc. | 42.68% | 18.55% | 87.73% | 94.07% | -15.58% | 97.89% | 42.86% | -3.46% | -10.56% | 29.64% |
KRYS Krystal Biotech, Inc. | 48.38% | 57.37% | 26.28% | 56.60% | 13.25% | 16.58% | 8.34% | 166.51% | 97.53% | 0.19% |
Correlation
The correlation between ANET and KRYS is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2017 | 0.24 |
The correlation between ANET and KRYS shifts across timeframes, from 0.09 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ANET:
$235.41B
KRYS:
$10.78B
ANET:
$2.92
KRYS:
$7.48
ANET:
64.09
KRYS:
48.93
ANET:
1.51
KRYS:
0.12
ANET:
24.56
KRYS:
26.38
ANET:
17.66
KRYS:
8.74
ANET:
$9.71B
KRYS:
$417.30M
ANET:
$6.17B
KRYS:
$387.24M
ANET:
$4.21B
KRYS:
$185.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANET vs. KRYS — Risk / Return Rank
ANET
KRYS
ANET vs. KRYS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arista Networks, Inc. (ANET) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANET | KRYS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.35 | ||
| Sortino ratioReturn per unit of downside risk | -1.91 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.54 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 2.69 | 9.11 | -6.41 |
| Martin ratioReturn relative to average drawdown | 5.57 | 23.76 | -18.19 |
Loading charts...
Drawdowns
ANET vs. KRYS - Drawdown Comparison
The maximum ANET drawdown since its inception was -52.20%, roughly equal to the maximum KRYS drawdown of -53.42%. Use the drawdown chart below to compare losses from any high point for ANET and KRYS.
Loading charts...
Drawdown Indicators
| ANET | KRYS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.20% | -53.42% | +1.22% |
Max Drawdown (1Y)Largest decline over 1 year | -28.33% | -15.94% | -12.39% |
Max Drawdown (3Y)Largest decline over 3 years | -50.42% | -42.26% | -8.16% |
Max Drawdown (5Y)Largest decline over 5 years | -50.42% | -44.55% | -5.87% |
Max Drawdown (10Y)Largest decline over 10 years | -52.20% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -3.26% | +3.26% |
Average DrawdownAverage peak-to-trough decline | -15.33% | -16.04% | +0.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.67% | 6.10% | +7.57% |
Volatility
ANET vs. KRYS - Volatility Comparison
Arista Networks, Inc. (ANET) has a higher volatility of 18.52% compared to Krystal Biotech, Inc. (KRYS) at 9.28%. This indicates that ANET's price experiences larger fluctuations and is considered to be riskier than KRYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANET | KRYS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.52% | 9.28% | +9.24% |
Volatility (6M)Calculated over the trailing 6-month period | 42.99% | 27.49% | +15.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.67% | 38.78% | +15.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.88% | 76.40% | -28.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.12% | 73.88% | -28.76% |
Dividends
ANET vs. KRYS - Dividend Comparison
Neither ANET nor KRYS has paid dividends to shareholders.
Financials
ANET vs. KRYS - Financials Comparison
This section allows you to compare key financial metrics between Arista Networks, Inc. and Krystal Biotech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ANET vs. KRYS - Profitability Comparison
ANET - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Arista Networks, Inc. reported a gross profit of 1.68B and revenue of 2.71B. Therefore, the gross margin over that period was 61.9%.
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Krystal Biotech, Inc. reported a gross profit of 110.03M and revenue of 116.36M. Therefore, the gross margin over that period was 94.6%.
ANET - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Arista Networks, Inc. reported an operating income of 1.16B and revenue of 2.71B, resulting in an operating margin of 42.7%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Krystal Biotech, Inc. reported an operating income of 53.69M and revenue of 116.36M, resulting in an operating margin of 46.1%.
ANET - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Arista Networks, Inc. reported a net income of 1.02B and revenue of 2.71B, resulting in a net margin of 37.8%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Krystal Biotech, Inc. reported a net income of 55.93M and revenue of 116.36M, resulting in a net margin of 48.1%.
Frequently Asked Questions
ANET and KRYS have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANET has higher volatility (18.52%) compared to KRYS (9.28%). In terms of maximum drawdown, ANET dropped -52.20% vs KRYS's -53.42%.
KRYS currently has the higher Sharpe Ratio (3.74 vs 1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANET and KRYS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer